Adapting Alzheimer’s Trials to a New Therapeutic Landscape: Early Detection and Operational Complexities

Adapting Alzheimer’s Trials to a New Therapeutic Landscape: Early Detection and Operational Complexities

Speakers:
Andreas Schreiner, MD
Senior Vice President, Medical Affairs, Neuroscience & Analgesia
Chris Foster, PhD
Senior Project Manager, Neuroscience